304463-32-9Relevant academic research and scientific papers
RCAI-61 and related 6′-modified analogs of KRN7000: Their synthesis and bioactivity for mouse lymphocytes to produce interferon-γ in vivo
Tashiro, Takuya,Nakagawa, Ryusuke,Shigeura, Tomokuni,Watarai, Hiroshi,Taniguchi, Masaru,Mori, Kenji
, p. 3066 - 3079 (2013/07/28)
We synthesized ten new analogs of 6′-modified KRN7000 (A): RCAI-58, 61, 64, 83, 85-87, 113, 119, and 125. They could be synthesized by α-selective galactosylation of ceramide 9 with the 6-modified d-galactopyranosyl fluorides (8a-8f) or l-arabinopyranosyl
NOVEL GLYCOLIPID AND USE THEREOF
-
Page/Page column 20-21, (2011/02/17)
The present invention provides a novel glycolipid effective for cancer treatment and the like and a novel synthetic intermediate therefor, as well as a medicament containing the novel glycolipid and the like. A compound represented by the following formul
RCAI-61, the 6′-O-methylated analog of KRN7000: its synthesis and potent bioactivity for mouse lymphocytes to produce interferon-γ in vivo
Tashiro, Takuya,Nakagawa, Ryusuke,Inoue, Sayo,Shiozaki, Masao,Watarai, Hiroshi,Taniguchi, Masaru,Mori, Kenji
scheme or table, p. 6827 - 6830 (2009/04/14)
RCAI-61, the 6′-O-methylated analog of KRN7000, and six other analogs with modified 6′-position of the galactose moiety of KRN7000 were synthesized to examine their bioactivity for mouse lymphocytes. Methyl α-d-galactopyranoside was the starting material
